These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Rodríguez-Vita J; Sánchez-López E; Esteban V; Rupérez M; Egido J; Ruiz-Ortega M Circulation; 2005 May; 111(19):2509-17. PubMed ID: 15883213 [TBL] [Abstract][Full Text] [Related]
4. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells. Shyu KG; Chen SC; Wang BW; Cheng WP; Hung HF Clin Sci (Lond); 2012 Jan; 122(1):33-42. PubMed ID: 21806545 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II stimulates apoptosis via TGF-beta1 signaling in ventricular cardiomyocytes of rat. Schröder D; Heger J; Piper HM; Euler G J Mol Med (Berl); 2006 Nov; 84(11):975-83. PubMed ID: 16924465 [TBL] [Abstract][Full Text] [Related]
7. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts. Li L; Fan D; Wang C; Wang JY; Cui XB; Wu D; Zhou Y; Wu LL Cardiovasc Res; 2011 Jul; 91(1):80-9. PubMed ID: 21367774 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of pravastatin, simvastatin, and atorvastatin on Ca2+ release and vascular reactivity. Tesfamariam B; Frohlich BH; Gregg RE J Cardiovasc Pharmacol; 1999 Jul; 34(1):95-101. PubMed ID: 10413074 [TBL] [Abstract][Full Text] [Related]
16. TGF-β-operated growth inhibition and translineage commitment into smooth muscle cells of periodontal ligament-derived endothelial progenitor cells through Smad- and p38 MAPK-dependent signals. Yoshida M; Okubo N; Chosa N; Hasegawa T; Ibi M; Kamo M; Kyakumoto S; Ishisaki A Int J Biol Sci; 2012; 8(7):1062-74. PubMed ID: 22949889 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137 [TBL] [Abstract][Full Text] [Related]